Figure 6.
(a) Sequence alignment and receptor agonist potencies of Oxyntomodulin (OXM) and related peptides. Conserved residues are highlighted: (b) Structure of a Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonist and (c) in vitro receptor agonist potencies (cAMP release) against mGLP1R and mGCGR and ED50 (nM) in the ex vivo mouse liver glycogenolysis assay (mGlyco).